MedTrace Logo

Post Approval Commitment Study

NCT01444729 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 305

Last updated 2017-10-26

No results posted yet for this study

Summary

An agreement has been made to conduct a post-approval commitment study that provides supplementary information relating to the use of Xiapex® as well as other non-pharmacological treatments for Dupuytren's contracture by health care professionals in a real world clinical setting.

Conditions

  • Dupuytren's Contracture

Interventions

DRUG

Xiapex

Xiapex administration will follow SMPC

PROCEDURE

surgery

Non-pharmacological treatment

Sponsors & Collaborators

  • Endo Pharmaceuticals

    lead INDUSTRY

Principal Investigators

  • Veronica Urdaneta · Endo

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2015-11-30
Completion
2015-11-30

Countries

  • Norway
  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01444729 on ClinicalTrials.gov